Christiane Amanpour, the popular British-Iranian TV host with the Cable News Network (CNN), has told her viewers that she has been diagnosed with ovarian cancer.
The 63-year old told her viewers Monday night that she has had successful major surgery to remove it and that she is undergoing several months of chemotherapy.
She made the revelation at the beginning of her daily program, Focused on International News.
She said, “During that time, like millions of women around the world, I have been diagnosed with ovarian cancer.
“I’ve had successful major surgery to remove it and I’m now undergoing several months of chemotherapy for the very best possible long-term prognosis.”
“I’m telling you this in the interest of transparency,” she said. “But in truth mostly as a shout out to early diagnosis. To urge women to educate themselves on this disease to get all the regular screenings and scans that you can, to always listen to your body, and of course, to ensure your legitimate medical concerns are not dismissed or diminished.”
Amanpour hosts the network’s flagship international affairs program. She has worked for the network since 1983.
Her reporting has been recognized with several awards, including 11 News and Documentary Emmy Awards, four Peabody Awards, three DuPont-Columbia Awards, and two George Polk Awards.
She has also received several honorary degrees and is a UNESCO goodwill ambassador for freedom of the press and the safety of journalists.
In a video making waves on social media platforms, Nigerians have reacted with mixed feelings…
A popular Nigerian TikToker identified simply as Seaking has been arrested by operatives of the…
Throughout history, some individuals have endured extraordinarily long prison sentences, with their stories reflecting the…
There is growing tension in Modakeke, Osun State, following the alleged arrest of two lovers,…
A victim of the stampede that occurred in Ibadan, Oyo State capital, which has claimed…
The vibrant Osun State is no stranger to captivating events and headlines that draw attention…
This website uses cookies.